Genetic Technologies
GENE
#10486
Rank
S$4.8 M
Marketcap
S$0.99
Share price
0.00%
Change (1 day)
-69.71%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : S$0.75 Million

According to Genetic Technologies's latest financial reports the company's total debt is S$0.75 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30S$0.79 M66.38%
2023-06-30S$0.47 M-23.58%
2022-06-30S$0.62 M202.75%
2021-06-30S$0.2 M-55.32%
2020-06-30S$0.46 M
2019-06-30N/A
2015-06-30S$0.02 M-99.12%
2014-06-30S$2.93 M
2013-06-30N/A-100%
2012-06-30S$0.02 M-74.14%
2011-06-30S$0.08 M-80.07%
2010-06-30S$0.44 M2.79%
2009-06-30S$0.43 M11.86%
2008-06-30S$0.38 M-42.86%
2007-06-30S$0.68 M-65.8%
2006-06-30S$1.98 M-24.58%
2005-06-30S$2.63 M220.08%
2004-06-30S$0.82 M0.86%
2003-06-30S$0.81 M
2002-06-30N/A-100%
2001-06-30S$0.11 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
S$0.71 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S$0.27 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$8.46 B 1,114,666.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$8.27 B 1,089,417.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$3.81 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
S$21.84 B 2,877,509.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$46.23 B 6,091,090.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
S$1.02 B 135,198.52%๐Ÿ‡บ๐Ÿ‡ธ USA